President and CEOOfficers of the CorporationBoard of TrusteesLeadership CouncilHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Adult ClinicPediatricsEye CareBillingInfo for Healthcare ProfessionalsDiabetes Information & Resources
50-Year Medalist StudyClinical Research
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternational
Give NowGet InvolvedEventsTributes & Special OccasionsCorporate & Foundation EngagementLegacy GivingWays to GivePhilanthropy TeamPublications

Joslin Extends Its China Connections

Robert Stanton, M.D., doing rounds in China

Wednesday, December 01, 2010

“China is the country with the most cases of diabetes—100 million or more—and they’re working very hard to raise their level of diabetes care,” notes Robert Stanton, M.D., head of the Joslin Clinic’s Nephrology Section.

Visiting four Chinese cities this fall, Dr. Stanton gave presentations about the latest advances in diagnosing, treating and managing patients with diabetic kidney disease. Additionally, he discussed his own research about how diabetes may diminish a crucial enzyme that produces the body’s main antioxidant, thus potentially leading to kidney and blood vessel complications.

During his trip, Dr. Stanton, who first visited China in 2005, picked up two more honorary professorships, from Tianjin Medical University and Luzhou Medical College. He also enjoyed banquets in his honor, toured historical sites and chatted with Chinese children who happily tried out their English and had heard of Harvard University.

“The Harvard and Joslin names carry a lot of weight and prestige in China,” notes Dr. Stanton, who is also an associate professor of medicine at Harvard Medical School.

He is among a number of Joslin researchers and clinicians whose ties with Chinese medical institutions have grown along with the numbers of Chinese postdoctoral researchers in their labs.

“Many postdocs who were trained by us are now in various academic positions in China,” says William Hsu, M.D., a frequent visitor to China and head of Joslin’s Asian Clinic. “In addition, through Joslin’s Asian American Diabetes Initiative outreach, we have lectured in many major cities in China.”

In addition to Drs. Stanton and Hsu, other Joslin researchers and clinicians such as George King, M.D., Alessandro Doria, M.D., Ph.D., and Edward Feener, Ph.D., have visited China to lecture and set up joint studies. “We expect to have many more collaborative interactions in the near future,” says Dr. King, Joslin’s Chief Scientific Officer, who is also honorary director of a diabetes center at Fu Dan University in Shanghai.

Dr. Robert Stanton doing rounds in China

Page last updated: September 23, 2018